Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD)
Clinical trial NCT06184360 · COMPLETED
Trial details
- NCT number
- NCT06184360
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-31
- Primary completion
- 2022-06-30
- Enrollment
- 2079
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.